Voices
Naveen Pemmaraju: Pooled Analysis on Dasatinib Outcomes
Naveen Pemmaraju/ youtube.com

Naveen Pemmaraju: Pooled Analysis on Dasatinib Outcomes

Naveen Pemmaraju, Professor in Department of Leukemia at UT MD Anderson Cancer Center, shared a post X:

“Important, clinically relevant paper led by Fadi Hadad and  UT MD Anderson just out in CLML.”

Title: Outcomes of Patients Treated With Dasatinib 50 mg/d: A Pooled Analysis

Authors: Fadi  Haddad, Elias Jabbour, Koji Sasaki, Samuel Black, Jonathan Michael Savoy, Yesid Alvarado, Gautam Borthakur, Naveen Pemmaraju, Musa Yilmaz, Sara Delasalla, Ghayas  Issa, Hagop Kantarjian

Read The Full Article.

Naveen Pemmaraju: Pooled Analysis on Dasatinib Outcomes

Other Articles Featuring Naveen Pemmaraju on OncoDaily.

cancer CLML Elias Jabbour Fadi Hadad Fadi Haddad Gautam Borthakur Ghayas Issa Hagop Kantarjian Jonathan Michael Savoy Koji Sasaki Musa Yilmaz Naveen Pemmaraju OncoDaily Oncology Samuel Black Sara Delasalla Yesid Alvarado